Hot Pursuit
Prev Next
As on Jan 27, 2020 12:00 AM Your results on : Hot Pursuit    
Dr Reddy's Labs jumps after Q3 results
27-Jan-2020 (12:30)
On a consolidated basis, the drug major recorded net loss of Rs 569.70 crore in Q3 December 2019 compared with net profit of Rs 485.20 crore in Q3 December 2018.

Consolidated revenues rose 14% to 4383.80 crore in Q3 December 2019 over Q3 December 2018. EBITDA rose 24% to Rs 1074 crore year-on-year (YoY). EBITDA margin stood at 24.5% in Q3 December 2019, higher than 22.5% in Q3 December 2018. The result was declared during trading hours today, 27 January 2020.

The company reported pre-tax loss of Rs 527.40 crore in Q3 December 2019 compared with pre-tax profit of Rs 580.50 crore in Q3 December 2018, primarily on account of impairment of intangible assets. Excluding impairment, profit before tax stood at Rs 790 crore in Q3 December 2019. Income tax expense fell 55.61% to Rs 42.30 crore YoY.

In December 2019 there has been a generic launch and an authorized generic launch for the product Nuvaring, which has led to a considerable erosion in the value of this product for the company, and accordingly the firm took an impairment charge of Rs 1110 crore ($156.5 million). In addition to this, considering the current market dynamics, the firm took an impairment charge of Rs 210 crore on the intangibles pertaining to other products. In total, we have taken an impairment of Rs 1320 crore on the intangible assets for this quarter. In Q2 September 2019, the company had an impairment charge on Rs 360 crore.

Commenting on the results, co-chairman and MD, GV Prasad said The current quarter performance has been good across all our businesses and we achieved strong EBITDA margins. The profits were impacted due to trigger based impairment charge taken on a few products including gNuvaring. We continue to focus on execution and have made significant progress on quality systems and operational efficiencies.

Dr Reddy's Laboratories offers a portfolio of products and services including Active Pharmaceutical Ingredients (APIs), custom pharmaceutical services, generics, biosimilars and differentiated formulations. Its major markets include - USA, India, Russia & CIS countries, and Europe.

Bharat Immunological & Biological Corporation Ltd leads gainers in 'B' group
27-Jan-2020 (12:15)
Edelweiss Financial Services Ltd leads gainers in 'A' group
27-Jan-2020 (12:00)
Nitco tumbles after lock out at Alibaug unit
27-Jan-2020 (11:48)
DCB Bank firms up after Q3 net profit up 12.3%
27-Jan-2020 (11:43)
JSW Steel melts after Q3 net profit plunges 87%
27-Jan-2020 (11:01)
Wendt (India) tumbles after Q3 PAT falls 60%
27-Jan-2020 (10:58)
Volumes spurt at APL Apollo Tubes Ltd counter
27-Jan-2020 (11:00)
Prestige Estates Projects jumps after robust Q3 outcome
27-Jan-2020 (10:39)
Consumer Durables shares gain
27-Jan-2020 (10:00)
Healthcare stocks edge higher
27-Jan-2020 (10:00)
Real Estate shares gain
27-Jan-2020 (10:00)
JSW Steel Ltd Falls 3.88%, S&P BSE Metal index Drops 2.49%
27-Jan-2020 (09:45)
ICICI Bank rises after good Q3 results
27-Jan-2020 (09:20)
Prestige Estates Projects Ltd Spikes 4.92%
27-Jan-2020 (09:30)
Bank of Baroda declines after poor Q3 numbers
27-Jan-2020 (09:26)
Biocon slides after API facility gets 5 observations
27-Jan-2020 (09:23)
APL Apollo Tubes soars after solid Q3 numbers
27-Jan-2020 (09:19)
Info Edge soars on launching Rs 100 Cr VC fund to invest in tech firms
24-Jan-2020 (15:08)
Zensar Technologies Ltd leads losers in 'A' group
24-Jan-2020 (15:00)
Connect with us :   
About us
Our Services
Core Values
Investor Relations
Product & Services
Institutional Broking
Clearing Services
Trade & Products
Globe Connect Pro
Globe Trade Smart
Globe Connect Mobile/Tablet
Globe News Connect
Globe e-KYC Application
NSDL e-KYC Signer Application
Back Office
Back Office
KYC/KDC Status
Mutual Fund
RMS Policy
Download Forms
Useful Links
Exchange Holidays
Anti-Money Laundering Policy
Policies, Procedures, Rights, Obligations and RDD
Additional Policy and Procedures

Funds Payout Policy

Shortages Obligation Arising Out Of Internal Netting of Trades

Policies of Globe Commodities Limited
Guidance Note on FATCA and CRS May 2016
Right and Obligation, RDD, Guidance Note in Vernacular Language - Equity | Commodity
Additional Risk Disclosure for Trading into Commodity options
In case of any grievances pleae write to / (For Trading) (For DP) (For PMS) (For Commodities)
Equity SEBI Registration No INZ000177137. Exchange Registration Nos NSE : TM No. - 06637, Clearing No.- M50302 | BSE : Clearing No.- 3179 | MSEI : TM Code-1004, Clearing Member Code- 4 | SEBI Registration for DP : IN-DP-NSDL-97-99, NSDL- DP ID: IN300966, CDSL DP ID: 12020600 | SEBI Research Analysts Registration No. INH100001187 | SEBI PMS Registration No. INP000002361
* Through subsidiary Globe Commodities Ltd. --> Commodity SEBI Regn. No. - INZ000024939, Exchange Regn. Nos. - MCX CM ID: 8550 TM ID: 10735, NCDEX CM ID: M50011 TM ID: 00012, NMCE ID: CL0111, ICEX ID: 1009, NCDXSPOT-CR-07-10011,
** Through step in subsidiary Globe Comex International DMCC --> DGCX **TM Id.1064, CM Id.3064*
"We also do Pro-Account trading in Commodity Segment.."
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
Attention Investors:
"Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your Stock Brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of investors"
"Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL/CDSL on the same day......................issued in the interest of investors."
"No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
© 2013 Globe Capital Market Limited. All rights reserved
Designed, Developed and Content powered by CMOTS Infotech (ISO 9001:2015 Certified) Privacy Policy Disclaimer Terms and Conditions